The State Medical Board of Ohio has rescinded current office-based opioid treatment rules and has issued the following new medication-assisted treatment rules which will be effective on Tuesday, April 30:
Medication-Assisted Treatment Rules effective Tuesday, April 30:
Physician rules applicable to medication-assisted treatment:
- 4731-33-01: Definitions
- 4731-33-03 Office based treatment for opioid addiction
- 4731-33-04 Medication-assisted treatment using naltrexone.
Physician assistant rules applicable to medication-assisted treatment:
- 4730-4-01: Definitions
- 4730-4-03: Office based treatment for opioid addiction
- 4730-4-04: Medication-assisted treatment using naltrexone.
Even when you think you are informed, there are things out there waiting to trip you up. Until reading this, I wasn’t aware the State regulated naltrexone (Revia/Vivitrol) for opioids like they do buprenorphine. While the rest of the country is trying to increase access to Vivitrol, Ohio continues to suppress it through regulatory burden.
Good Morning,
I am trying to confirm some information I came across regarding state imposed Buprenorphine prescribing limits. Page 4 of the link below states a set of restrictions as to the number of patients to whom a provider may prescribe Buprenorphine in OH. Can you please tell me if this is still in effect? I have tried to locate the actual regulation, but cannot find anything other than this one document which states a state imposed limit.
Please let me know if you have any questions, or where I can find the regulation regulating this matter.
https://www.supremecourt.ohio.gov/sites/specDockets/2018/materials/B3/B3.pdf
Thank you,
Daniel DiRenzo, Esq
Regulatory Affairs Specialist
Groups Recover Together